# MOVIPREP
> **NDA021881** · New Drug Application · Sponsor: SALIX PHARMS · Approved 2006-08-02
## Drug
- **FDA Application Number:** NDA021881
- **Application type:** New Drug Application
- **Brand name:** MOVIPREP
- **Generic name:** POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE
- **Active ingredients:** ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SALIX PHARMS
- **Manufacturer:** Salix Pharmaceuticals, Inc.
- **First approval:** 2006-08-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021881)
---
*MORVS · CC0 1.0*